Modern Diagnostic & Research Centre
Close ·
Key Fundamentals
SMEHealthcare ServicesHealthcarePrice-based figures at the close · TTM
- ROCE
- 12.50%
- Debt to Equity
- 0.63
- EPS (TTM)
- —
- Book Value
- ₹38.77
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 1.47
- ROE
- 13.20%
- Dividend Yield
- 0.00%
- EBITDA
- ₹13.60 Cr
- 52W High
- ₹100.00
- 52W Low
- ₹45.00
Key Insights
Strengths
1- Company has a good return on equity (ROE) track record: 3 Years ROE 31.0%
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 8 | 1 |
| Oscillators | Bearish | 2 | 6 | 1 |
| Moving Averages | Strong Bearish | 8 | 2 | 0 |
Oscillators
Bearish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 37.82
- Neutral
- MACD (12,26,9)
- −2.78
- Bearish
- SMA (50)
- 63.67
- Bearish
- SMA (200)
- —
- Neutral
As of
Growth Rate
From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 3Y | +13.88% |
|---|---|
| 1Y | +6.62% |
Net profit
| 3Y | Turned to profit |
|---|---|
| 1Y | −41.73% |
Operating cash flow
| 3Y | Turned positive |
|---|---|
| 1Y | −72.52% |
Operating margin· change in pp
| 3Y | +17.15 pp |
|---|---|
| 1Y | −7.82 pp |
Trailing twelve months: Fewer than eight quarters are reported, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2022 | ₹60.21 Cr |
|---|---|
| Mar 2023 | ₹56.28 Cr |
| Mar 2024 | ₹67.13 Cr |
| Mar 2025 | ₹77.95 Cr |
| Mar 2026 | ₹83.11 Cr |
Net profit by year
| Mar 2022 | −₹1.45 Cr |
|---|---|
| Mar 2023 | −₹5.73 Cr |
| Mar 2024 | ₹5.79 Cr |
| Mar 2025 | ₹9.01 Cr |
| Mar 2026 | ₹5.25 Cr |
Quarterly Results
₹ Cr| Particulars | Mar 2026 |
|---|---|
| Sales | 39.92 |
| Expenses | 34.84 |
| Operating Profit | 5.08 |
| OPM % | 12.73% |
| Other Income | 0.41 |
| Interest | 1.46 |
| Depreciation | 2.83 |
| PBT | 1.2 |
| Tax % | −73.33% |
| Net Profit | 2.08 |
| EPS (₹) | 1.38 |
Profit & Loss
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 60.21 | 56.28 | 67.13 | 77.95 | 83.11 |
| Expenses | 54.19 | 57.26 | 55.99 | 59.84 | 70.3 |
| Operating Profit | 6.02 | −0.98 | 11.14 | 18.11 | 12.81 |
| OPM % | 10% | −1.74% | 16.59% | 23.23% | 15.41% |
| Other Income | 0.35 | 0.32 | 1.46 | 0.86 | 1.03 |
| Interest | 1.57 | 1.41 | 1.81 | 1.91 | 2.66 |
| Depreciation | 3.66 | 3.87 | 3.92 | 4.19 | 5.19 |
| PBT | 1.14 | −5.94 | 6.87 | 12.87 | 5.99 |
| Tax % | 227.19% | −3.54% | 15.57% | 29.99% | 12.19% |
| Net Profit | −1.45 | −5.73 | 5.79 | 9.01 | 5.25 |
| EPS (₹) | −1.32 | −5.21 | 5.26 | 8.19 | 3.48 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 11 | 15.1 |
| Reserves | 10.7 | 4.96 | 10.76 | 9.77 | 43.45 |
| Borrowings | 20.4 | 15.31 | 20.46 | 22.09 | 37.1 |
| Other Liabilities | 16.6 | 15.27 | 17.26 | 21.71 | 22.95 |
| Total Liabilities | 48.7 | 36.54 | 49.48 | 64.57 | 119 |
| Fixed Assets | 24.31 | 23.67 | 27.04 | 30.65 | 48.09 |
| CWIP | 0.75 | 0 | 3.6 | 9.11 | 10.18 |
| Investments | 5.29 | 0.11 | 0.21 | 0.23 | 16.97 |
| Other Assets | 18.35 | 12.76 | 18.63 | 24.58 | 43.36 |
| Total Assets | 48.7 | 36.54 | 49.48 | 64.57 | 119 |
Cash Flow
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 3.64 | −0.12 | 7.93 | 13.9 | 3.82 |
| Investing | −5.2 | 2.11 | −11.03 | −13.31 | −40.29 |
| Financing | 4.5 | −6.47 | 3.36 | −0.22 | 45.08 |
| Net Cash Flow | 2.94 | −4.48 | 0.26 | 0.37 | 8.62 |
| Free Cash Flow | −1.49 | −3.27 | −3.04 | 0.58 | −19.88 |
| CFO/EBITDA | 52 | 12 | 60 | 98 | 36 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 54.56 | 52.27 | 56.28 | 59.75 | 69.3 |
| Inventory Days | 25.9 | 40.62 | 61.45 | 95.47 | 120 |
| Days Payable | 172 | 171 | 177 | 160 | 196 |
| Cash Conversion Cycle | −91.92 | −77.94 | −59.39 | −5.06 | −7.55 |
| Working Capital Days | −43.95 | −58.82 | −34.74 | −37.79 | −41.68 |
| ROCE % | — | −17.24% | 32.75% | 39.37% | 12.48% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Modern Diagnostic & Research Centre insights
48 extracted metrics across FY22–FY26.
Documents
- General announcements 13 Oct 2026
- General announcements 15 Sep 2026
Frequently Asked Questions about Modern Diagnostic & Research Centre
What does Modern Diagnostic & Research Centre Ltd do?
Where is Modern Diagnostic & Research Centre Ltd (MDRC) listed?
Which sector does Modern Diagnostic & Research Centre Ltd belong to?
What is the 52-week high and low of Modern Diagnostic & Research Centre Ltd?
What is the Return on Equity (ROE) of Modern Diagnostic & Research Centre Ltd?
Company Information
Incorporated in 1985, Modern Diagnostic & Research Centre Limited (MDRC) is a diagnostic chain in India, offering a comprehensive range of pathology and radiology services.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544673.md for Modern Diagnostic & Research Centre Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.